Tonix Pharmaceuticals Holding (TNXP) executive compensation, 2026 proxy

Seth Lederman, Chief Executive Officer, was paid $3.2M in 2025, up 75% from $1.8M the year before.

Filed
March 30, 2026
Annual meeting
May 7, 2026
Pay year
2025
Named executives
4
CEO total pay
$3.2M+75% vs prior year
CEO 2025 Total Compensation
$3,168,830Increase from prior year
CEO 2025 Base Salary
$702,000Up from $675,000
CEO Option Awards
$1,870,130Grant date fair value

How Lederman was paid

$3.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary22%Bonus19%Option awards59%

Named executive officers

ExecutiveTotal
Seth LedermanChief Executive Officer$3,168,830
Jessica MorrisChief Operations Officer$1,226,269
Bradley SaengerChief Financial Officer$1,143,513
Gregory SullivanChief Medical Officer$1,216,542

What changed and why

  • $3.2MSeth Lederman received total compensation of $3,168,830 in fiscal 2025 compared to $1,809,767 in fiscal 2024.
  • Option awards comprised the largest component of executive compensation for named executive officers in 2025.
  • Annual option grants were determined independently of material nonpublic information releases.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.